Panagora Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-4,716
| Closed | -$92K | – | 2483 |
|
|
2018
Q1 | $92K | Hold |
4,716
| – | – | ﹤0.01% | 1878 |
|
|
2017
Q4 | $79K | Sell |
4,716
-140,401
| -97% | -$2.57M | ﹤0.01% | 1953 |
|
|
2017
Q3 | $2.95M | Sell |
145,117
-19,838
| -12% | -$379K | 0.01% | 720 |
|
|
2017
Q2 | $2.66M | Sell |
164,955
-220,371
| -57% | -$3.26M | 0.01% | 763 |
|
|
2017
Q1 | $4.87M | Sell |
385,326
-102,084
| -21% | -$1.23M | 0.02% | 598 |
|
|
2016
Q4 | $6.46M | Buy |
487,410
+9,102
| +2% | +$156K | 0.03% | 486 |
|
|
2016
Q3 | $11.3M | Buy |
478,308
+150,028
| +46% | +$4.03M | 0.05% | 337 |
|
|
2016
Q2 | $9.46M | Buy |
328,280
+98,028
| +43% | +$3.2M | 0.05% | 378 |
|
|
2016
Q1 | $7.37M | Buy |
230,252
+81,668
| +55% | +$2.87M | 0.04% | 449 |
|
|
2015
Q4 | $6.35M | Buy |
148,584
+28,923
| +24% | +$1.16M | 0.03% | 485 |
|
|
2015
Q3 | $4.21M | Buy |
119,661
+33,986
| +40% | +$1.53M | 0.02% | 548 |
|
|
2015
Q2 | $3.93M | Sell |
85,675
-4,362
| -5% | -$207K | 0.02% | 588 |
|
|
2015
Q1 | $4.22M | Buy |
90,037
+2,834
| +3% | +$113K | 0.02% | 555 |
|
|
2014
Q4 | $2.76M | Sell |
87,203
-3,515
| -4% | -$103K | 0.01% | 634 |
|
|
2014
Q3 | $2.15M | Sell |
90,718
-165,520
| -65% | -$4.24M | 0.01% | 724 |
|
|
2014
Q2 | $7.68M | Buy |
256,238
+90,729
| +55% | +$2.45M | 0.04% | 412 |
|
|
2014
Q1 | $4.37M | Buy |
+165,509
| New | +$4.14M | 0.02% | 590 |
|
Panagora Asset Management's IPXL Position: Q2 2018 in Review
Panagora Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 4,716 shares — an estimated $92K sold.
Panagora Asset Management first reported a position in IPXL in Q1 2014 and held it in 17 quarters. The position peaked at $11.3M in Q3 2016. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Panagora Asset Management reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Panagora Asset Management sold 4,716 Impax Laboratories, Inc. shares in Q2 2018, an estimated $92K.
- Panagora Asset Management first reported a position in Impax Laboratories, Inc. in Q1 2014 and held it in 17 quarters.
- Panagora Asset Management's Impax Laboratories, Inc. position peaked at $11.3M in Q3 2016.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Panagora Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.